Table 1.
ETC inhibitor | Oxygen consumption in the indicated strain (nmol/min/ml/Klett unit) |
||
---|---|---|---|
WT | GOA31 | GOA32 | |
No inhibitor | 309.6 ± 43.0 | 61.1 ± 10.8 | 320.8 ± 37.0 |
10 μM Rotenone | 17.6 ± 1.05 | 0.6 ± 0.3 | 10.8 ± 3.08 |
10 μM AA | 58.6 ± 10.5 | 46.0 ± 12.0 | 55.2 ± 13.5 |
1 mM KCN | 59.58 ± 3.0 | 32.43 ± 4.12 | 58.16 ± 10.01 |
10 mM KCN | 41.66 ± 3.4 | 25.66 ± 3.56 | 45.37 ± 3.86 |
2 mM Na3N | 62.6 ± 13.0 | 47.1 ± 10.0 | 54.1 ± 8.01 |
5 mM SHAM | 165.7 ± 28.3 | 148.0 ± 25.6 | 204.5 ± 36.6 |
5 mM SHAM + 1 mM KCN | 65.64 ± 4.63 | 46.97 ± 3.56 | 67.26 ± 8.69 |
6 μM TTFA | 83.04 ± 10.63 | 52.88 ± 4.53 | 90.41 ± 15.33 |
200 μM Flavone | 89.49 ± 5.24 | 63.96 ± 8.67 | 99.09 ± 18.86 |
6 μM TTFA + 200μM flavone | 82.70 ± 3.86 | 42.75 ± 3.78 | 80.60 ± 2.63 |
5 mM SHAM + 200μM flavone | 60.23 ± 7.53 | 39.90 ± 5.21 | 67.18 ± 8.51 |